Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts

scientific article

Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/IJE/DYI164
P698PubMed publication ID16157617
P5875ResearchGate publication ID7604511

P50authorMatthias EggerQ19996372
Andrew BoulleQ53680127
François DabisQ56850448
Paula BraitsteinQ83393911
Eric BalestreQ117285335
P2093author name stringMauro Schechter
Eduardo Sprinz
James McIntyre
Martin Schneider
David Bangsberg
Paolo Miotti
Christian Laurent
Catherine Seyler
Gorana Capkun
Antiviral Therpapy in Lower Income Countries (ART-LINC) Study Group
Charles Kabugo
Stefan Van der Borght
W G Martin Brinkhof
P433issue5
P921main subjectanti-retroviral agentQ50430310
collaborationQ1145523
P304page(s)979-986
P577publication date2005-09-12
P1433published inInternational Journal of EpidemiologyQ6051393
P1476titleCohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts
P478volume34

Reverse relations

cites work (P2860)
Q37043399Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy
Q37043395Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America
Q38452995Brazilian psychosocial and operational research vis-à-vis the UNGASS targets
Q34718675Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Colla
Q37143745Children and HIV/AIDS: from research to policy and action in resource-limited settings
Q35945152Choice of first-line antiretroviral therapy regimen and treatment outcomes for HIV in a middle income compared to a high income country: a cohort study.
Q36628019Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy
Q36936569Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme
Q40665399Cohort Profile: The Khayelitsha antiretroviral programme, Cape Town, South Africa.
Q38880585Cohort profile: the paediatric antiretroviral treatment programmes in lower-income countries (KIDS-ART-LINC) collaboration
Q36273986Community-based ART distribution system can effectively facilitate long-term program retention and low-rates of death and virologic failure in rural Uganda
Q33777533Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014.
Q33803701Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa
Q28476337Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal
Q46172422Database-supported teleconferencing: an additional clinical mentoring tool to assist a multinational company HIV/AIDS treatment program in Africa
Q36941573Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies
Q37108925Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries
Q33399742Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings
Q36440576Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy
Q33750295Evaluation of three sampling methods to monitor outcomes of antiretroviral treatment programmes in low- and middle-income countries
Q42247975Four years of experience with antiretroviral therapy in adult patients in Karachi, Sindh, Pakistan.
Q34735495HIV Suppression among Patients on Treatment in Vietnam: A Review of HIV Viral Load Testing in a Public Urban Clinic in Ho Chi Minh City
Q34769839High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia
Q35074204High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lomé, Togo
Q34604679Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria
Q56786182Long-Term Outcomes of a National Expanded Access Program to Antiretroviral Therapy: The Chilean AIDS Cohort
Q37477423Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies
Q46709465Lopinavir/ritonavir monotherapy as maintenance treatment in HIV-infected individuals with virological suppression: results from a pilot study in Brazil
Q34320076Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings
Q34228301Measuring the quality of observational study data in an international HIV research network
Q33862806Mortality after failure of antiretroviral therapy in sub-Saharan Africa
Q38851677Mortality and survival patterns of people living with HIV-2
Q33574798Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings
Q46391119Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries
Q56530532Mortality of HIV-infected patients in low-income countries – Authors’ response
Q82029714Neuroepidemiology of HIV/AIDS
Q35910240No differences in clinical outcomes with the addition of viral load testing to CD4 cell count monitoring among HIV infected participants receiving ART in rural Uganda: Long-term results from the Home Based AIDS Care Project
Q58265885Prevalence and risk factors associated with syphilis in a cohort of HIV positive individuals in Brazil
Q33926747Prioritising prevention strategies for patients in antiretroviral treatment programmes in resource-limited settings
Q33798752Quality of data collection in a large HIV observational clinic database in sub-Saharan Africa: implications for clinical research and audit of care
Q30363938Responding to the HIV pandemic: the power of an academic medical partnership.
Q33388709Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya
Q51809092Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.
Q38378260Shifting the HIV Training and Research Paradigm to Address Disparities in HIV Outcomes
Q34208678Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring
Q37357222Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil
Q36628346The cost-effectiveness of antiretroviral therapy for treating HIV disease in the Caribbean
Q36942918Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries
Q35117177Tuberculosis in HIV programmes in lower-income countries: practices and risk factors
Q34062163Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America
Q34556999Women experience a better long-term immune recovery and a better survival on HAART in Lao People's Democratic Republic

Search more.